fbpx
Home > Blog > Seventeen Minutes of Science: Using Artificial Intelligence and Machine Learning to Understand Physician and Patient Decision-Making(Episode 11)

Seventeen Minutes of Science: Using Artificial Intelligence and Machine Learning to Understand Physician and Patient Decision-Making(Episode 11)

Stuck at home with nothing to do during this quarantine? Restless to still be learning and interacting with other scientists? You’re in luck! You can now tune in weekly to our virtual series “Seventeen Minutes of Science”. Every Tuesday at 11am PST / 2pm ET we will go live on Facebook to talk about science for (you guessed it) 17 minutes!

This week on 17 Minutes of Science: Using Artificial Intelligence and Machine Learning to Understand Patient and Physician Decision-Making with Briana Brownell.

Briana Brownell is the founder and CEO at Pure Strategy Inc. in Canada where they use artificial intelligence (AI) and machine learning (ML) to support and improve the business analytics of companies to get better ROI on data collection programs, improve customer experience and make better products. One of the areas their technology has been especially useful is in the healthcare industry to help understand physician and patient decision-making.

Join us as we talk with Briana Brownell about how artificial intelligence and machine learning can help us understand decision-making in the healthcare industry (and why that is important).

About The Author

InVivo Biosystems

InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts. An expert in CRISPR genome editing, InVivo Biosystems creates custom genome edited C. elegans and zebrafish models to enable aging and other disease studies. In addition, InVivo Biosystems provides in-vivo analytical services to produce data and insights for companies that need to make go/no-go decisions quickly in early-stage development of new compounds.

Share this articles

Facebook
Twitter
Pinterest
LinkedIn
InVivo Biosystems

About the Author:

Connect with us